Clinical Trials Browser

Terminated × Interventional × mirdametinib × Clear all

NCT05580770 2025-02-17

Mirdametinib + BGB-3245 in Advanced Solid Tumors

Phase 1/2 Terminated

Other solid neoplasm

Advanced Solid Tumor

NCT00174369 2009-03-17

MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung